Literature DB >> 19475324

The ADMIT series--issues in inhalation therapy. 2. Improving technique and clinical effectiveness.

Mariëlle E A C Broeders1, Joaquin Sanchis, Mark L Levy, Graham K Crompton, P N Richard Dekhuijzen.   

Abstract

Aerosol inhalation is considered the optimal route for administering the majority of drugs for the treatment of obstructive airways diseases. A number of Pressurised Metered-Dose and Dry Powder Inhalers are available for this purpose. However, inhalation of therapeutic aerosols is not without difficulty; it requires precise instructions on the inhalation manoeuvre, which is different from spontaneous normal breathing. Also, the characteristics of the inhaler device have to be suitable for the user. Available data indicate a frequent lack of knowledge demonstrated by health professionals and patients on the inhalation manoeuvre and handling of inhalers, resulting in a reduction of therapeutic benefit. This paper reviews the literature concerning the fundamental aspects of inhaler devices, inhalation manoeuvre and device selection, in an attempt to increase the knowledge of, and to optimise the clinical use of, therapeutic inhalers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19475324      PMCID: PMC6619237          DOI: 10.4104/pcrj.2009.00025

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  41 in total

1.  Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners.

Authors:  Mathieu Molimard; Paul Colthorpe
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-09-29       Impact factor: 2.849

2.  Real-world asthma management with inhaler devices in Switzerland-results of the asthma survey.

Authors:  Christian F Clarenbach; Laurent P Nicod; Malcolm Kohler
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Counseling of inhalation medicine perceived by patients and their healthcare providers: insights from North Cyprus.

Authors:  Onur Gültekin; Abdikarim Mohamed Abdi; Haider Al-Baghdadi; Mustafa Akansoy; Finn Rasmussen; Bilgen Başgut
Journal:  Int J Clin Pharm       Date:  2019-07-16

Review 4.  The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.

Authors:  Barbara P Yawn; Ibrahim Raphiou; Judith S Hurley; Anand A Dalal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

5.  Benefit of educational feedback for the use of positive expiratory pressure device.

Authors:  Gregory Reychler; Manon Jacquemart; William Poncin; Anne-Sophie Aubriot; Giuseppe Liistro
Journal:  Braz J Phys Ther       Date:  2015-09-01       Impact factor: 3.377

6.  In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing.

Authors:  Renishkumar R Delvadia; Xiangyin Wei; P Worth Longest; Jurgen Venitz; Peter R Byron
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2015-10-08       Impact factor: 2.849

7.  The Role of Inhalation Delivery Devices in COPD: Perspectives of Patients and Health Care Providers.

Authors:  Nicola A Hanania; Sidney Braman; Sandra G Adams; Ruth Adewuya; Arzu Ari; JoAnn Brooks; Donald A Mahler; Jill A Ohar; Jay Peters; Shahin Sanjar
Journal:  Chronic Obstr Pulm Dis       Date:  2018-04-01

Review 8.  Living with asthma and chronic obstructive airways disease: Using technology to support self-management - An overview.

Authors:  Deborah Morrison; Frances S Mair; Lucy Yardley; Sarah Kirby; Mike Thomas
Journal:  Chron Respir Dis       Date:  2016-08-10       Impact factor: 2.444

Review 9.  Practical aspects of inhaler use in the management of chronic obstructive pulmonary disease in the primary care setting.

Authors:  Barbara P Yawn; Gene L Colice; Rick Hodder
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-25

10.  Improper inhaler technique is associated with poor asthma control and frequent emergency department visits.

Authors:  Hamdan Al-Jahdali; Anwar Ahmed; Abdullah Al-Harbi; Mohd Khan; Salim Baharoon; Salih Bin Salih; Rabih Halwani; Saleh Al-Muhsen
Journal:  Allergy Asthma Clin Immunol       Date:  2013-03-06       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.